Immunoscreening of the extracellular proteome of colorectal cancer cells

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Klein Scory, Susanne ^a   Kübler, Salwa ^a   Diehl, Hanna ^a,b   Eilert Micus, Christina ^a   Reinacher Schick, Anke ^a   Stühler, Kai ^b   Warscheid, Bettina ^b,c   Meyer, Helmut E ^b   Schmiegel, Wolff ^a,d   Schwarte Waldhoff, Irmgard ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; AUTOANTIGEN; BIOLOGICAL MARKER; GLYOXALASE; GLYOXALASE DOMAIN CONTAINING PROTEIN 4; PROTEOME; SCLEROPROTEIN; SECRETOME; TUMOR PROTEIN; UNCLASSIFIED DRUG; AGRIN RECEPTOR; AUTOANTIBODY; GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SCREENING; ANTIGEN DETECTION; ANTIGENICITY; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; COLORECTAL CANCER; CONTROLLED STUDY; CROSS PRESENTATION; ELECTROSPRAY MASS SPECTROMETRY; EXOSOME; EXTRACELLULAR MATRIX; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNODETECTION; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE VESICLE; PROTEIN IMMOBILIZATION; PROTEIN ISOLATION; PROTEIN SECRETION; SEROLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; B LYMPHOCYTE; CHEMISTRY; COLORECTAL TUMOR; CYTOLOGY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEOMICS; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; B-LYMPHOCYTES; COLORECTAL NEOPLASMS; EXOSOMES; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN STRUCTURE, TERTIARY; PROTEOME; PROTEOMICS; RECEPTORS, GROWTH FACTOR; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 77950121516     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-70     Document Type: Article

References (58)

1. Tjalsma H, RMJ S, Swinkels DW. Immunoproteomics: From biomarker discovery to diagnostic applications. Proteomics Clin Appl 2008, 2:167-180.
2. Rauch J, Gires O. SEREX, Proteomex, AMIDA, and beyond: Serologixal screening technologies for target identification. Proteomics Clin Appl 2008, 2:355-371.
3. Caron M, Choquet-Kastylevsky G, Joubert-Caron R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 2007, 6:1115-1122. 10.1074/mcp.R600016-MCP200, 17376768.
4. Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 2005, 4:1123-1133. 10.1021/pr0500814, 2522321, 16083262.
5. Hardouin J, Lasserre JP, Sylvius L, Joubert-Caron R, Caron M. Cancer immunomics: from serological proteome analysis to multiple affinity protein profiling. Ann N Y Acad Sci 2007, 1107:223-230. 10.1196/annals.1381.024, 17804550.
6. Gunawardana CG, Diamandis EP. High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett 2007, 249:110-119. 10.1016/j.canlet.2007.01.002, 17306453.
7. Li WH, Zhao J, Li HY, Liu H, Li AL, Wang HX, Wang J, He K, Liang B, Yu M, Shen BF, Zhang XM. Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing. Proteomics 2006, 6:4781-4789. 10.1002/pmic.200500909, 16878294.
8. Diehl HC, Stühler K, Klein-Scory S, Volmer MW, Schöneck A, Bieling C, Schmiegel W, Meyer H, Schwarte-Waldhoff I. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery. Proteomics Clin Appl 2007, 1:47-61.
9. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
10. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. The biogenesis and functions of exosomes. Traffic 2002, 3:321-330. 10.1034/j.1600-0854.2002.30502.x, 11967126.
11. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004, 16:415-421. 10.1016/j.ceb.2004.06.003, 15261674.
12. Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006, 107:102-108. 10.1016/j.imlet.2006.09.005, 17067686.
13. van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J Biochem 2006, 140:13-21. 10.1093/jb/mvj128, 16877764.
14. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 2008, 15:80-88. 10.1038/sj.cdd.4402237, 17932500.
15. Mallegol J, van Niel G, Heyman M. Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Mol Dis 2005, 35:11-16. 10.1016/j.bcmd.2005.04.001, 15893486.
16. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001, 7:297-303. 10.1038/85438, 11231627.
17. Volmer MW, Stuhler K, Zapatka M, Schoneck A, Klein-Scory S, Schmiegel W, Meyer HE, Schwarte-Waldhoff I. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics 2005, 5:2587-2601. 10.1002/pmic.200401188, 15912508.
18. Wu CC, Chien KY, Tsang NM, Chang KP, Hao SP, Tsao CH, Chang YS, Yu JS. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 2005, 5:3173-3182. 10.1002/pmic.200401133, 16035111.
19. Sardana G, Marshall J, Diamandis EP. Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin Chem 2007, 53:429-437. 10.1373/clinchem.2006.077370, 17259234.
20. Lin CY, Tsui KH, Yu CC, Yeh CW, Chang PL, Yung BY. Searching cell-secreted proteomes for potential urinary bladder tumor markers. Proteomics 2006, 6:4381-4389. 10.1002/pmic.200600066, 16819731.
21. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins MG, Maitra A, Pandey A. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006, 5:157-171.
22. Kulasingam V, Diamandis EP. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol Cell Proteomics 2007, 6:1997-2011. 10.1074/mcp.M600465-MCP200, 17656355.
23. Wu CCCH, Chen SJ, Liu HP, Hsieh YY, Yu CJ, Tang R, Hsieh LL, Yu JS, Chang YS. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008, 8:316-332. 10.1002/pmic.200700819, 18203259.
24. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001, 121:337-349. 10.1053/gast.2001.26263, 11487543.
25. Théry C, Ostrowski M, E S. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593. 10.1038/nri2567, 19498381.
26. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995, 16:1034-1059. 10.1002/elps.11501601175, 7498127.
27. Heukeshoven J, Dernick R. Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 1988, 9:28-32. 10.1002/elps.1150090106, 2466645.
28. Nesterenko MV, Tilley M, Upton SJ. A simple modification of Blum's silver stain method allows for 30 minute detection of proteins in polyacrylamide gels. J Biochem Biophys Methods 1994, 28:239-242. 10.1016/0165-022X(94)90020-5, 8064118.
29. Volmer MW, Radacz Y, Hahn SA, Klein-Scory S, Stuhler K, Zapatka M, Schmiegel W, Meyer HE, Schwarte-Waldhoff I. Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a "secretome" analysis. Proteomics 2004, 4:1324-1334. 10.1002/pmic.200300703, 15188399.
30. Zhang W, Chait BT. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 2000, 72:2482-2489. 10.1021/ac991363o, 10857624.
31. Yates JR, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 1995, 67:1426-1436. 10.1021/ac00104a020, 7741214.
32. Schaefer H, Chervet JP, Bunse C, Joppich C, Meyer HE, Marcus K. A peptide preconcentration approach for nano-high-performance liquid chromatography to diminish memory effects. Proteomics 2004, 4:2541-2544. 10.1002/pmic.200300801, 15352228.
33. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2, 10612281.
34. Stephan C, Reidegeld KA, Hamacher M, van Hall A, Marcus K, Taylor C, Jones P, Muller M, Apweiler R, Martens L, Korting G, Chamrad DC, Thiele H, Bluggel M, Parkinson D, Binz PA, Lyall A, Meyer HE. Automated reprocessing pipeline for searching heterogeneous mass spectrometric data of the HUPO Brain Proteome Project pilot phase. Proteomics 2006, 6:5015-5029. 10.1002/pmic.200600294, 16927432.
35. Olver C, Vidal M. Proteomic analysis of secreted exosomes. Subcell Biochem 2007, 43:99-131. full_text, 17953393.
36. Yu S, Liu C, Su K, Wang J, Liu Y, Zhang L, Li C, Cong Y, Kimberly R, Grizzle WE, Falkson C, Zhang HG. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 2007, 178:6867-6875.
37. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 2006, 66:9290-9298. 10.1158/0008-5472.CAN-06-1819, 16982774.
38. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67:2912-2915. 10.1158/0008-5472.CAN-07-0520, 17409393.
39. Sabates-Bellver J, Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers H, Marra G. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007, 5:1263-1275. 10.1158/1541-7786.MCR-07-0267, 18171984.
40. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Harada T, Fujimoto M, Sakaida I, Okita K, Oka M, Nakamura K. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 2006, 6:3894-3900. 10.1002/pmic.200500346, 16767786.
41. Fujita Y, Nakanishi T, Hiramatsu M, Mabuchi H, Miyamoto Y, Miyamoto A, Shimizu A, Tanigawa N. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 2006, 12:6415-6420. 10.1158/1078-0432.CCR-06-1315, 17085654.
42. De Monte L, Sanvito F, Olivieri S, Vigano F, Doglioni C, Frasson M, Braga M, Bachi A, Dellabona P, Protti MP, Alessio M. Serological immunoreactivity against colon cancer proteome varies upon disease progression. J Proteome Res 2008, 7:504-514. 10.1021/pr070360m, 18179166.
43. Fiedler K, Parton RG, Kellner R, Etzold T, Simons K. VIP36, a novel component of glycolipid rafts and exocytic carrier vesicles in epithelial cells. Embo J 1994, 13:1729-1740. 395006, 8157011.
44. Fullekrug J, Scheiffele P, Simons K. VIP36 localisation to the early secretory pathway. J Cell Sci 1999, 112(Pt 17):2813-2821.
45. Campanelli JT, Ferns M, Hoch W, Rupp F, von Zastrow M, Hall Z, Scheller RH. Agrin: a synaptic basal lamina protein that regulates development of the neuromuscular junction. Cold Spring Harb Symp Quant Biol 1992, 57:461-472.
46. Hoch W, Campanelli JT, Harrison S, Scheller RH. Structural domains of agrin required for clustering of nicotinic acetylcholine receptors. Embo J 1994, 13:2814-2821. 395162, 8026466.
47. Bezakova G, Ruegg MA. New insights into the roles of agrin. Nat Rev Mol Cell Biol 2003, 4:295-308. 10.1038/nrm1074, 12671652.
48. VanSaun M, Werle MJ. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J Neurobiol 2000, 43:140-149. 10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.0.CO;2-K, 10770843.
49. Reif R, Sales S, Hettwer S, Dreier B, Gisler C, Wolfel J, Luscher D, Zurlinden A, Stephan A, Ahmed S, Baici A, Ledermann B, Kunz B, Sonderegger P. Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. Faseb J 2007, 21:3468-3478. 10.1096/fj.07-8800com, 17586728.
50. Qin WX, Wan F, Sun FY, Zhang PP, Han LW, Huang Y, Jiang HQ, Zhao XT, He M, Ye Y, Cong WM, Wu MC, Zhang LS, Yang NW, Gu JR. Cloning and characterization of a novel gene (C17orf25) from the deletion region on chromosome 17p13.3 in hepatocelular carcinoma. Cell Res 2001, 11:209-216. 10.1038/sj.cr.7290088, 11642406.
51. Molina H, Bunkenborg J, Reddy GH, Muthusamy B, Scheel PJ, Pandey A. A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 2005, 4:637-650. 10.1074/mcp.M500042-MCP200, 15723814.
52. Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, Lane Z, Crispin DA, Goodlett DR, Aebersold R, Bronner MP. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics 2007, 6:1331-1342. 10.1074/mcp.M700072-MCP200, 17496331.
53. Dantuma NPHC, Hoogstraten D. The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation. DNA Repair 2009, 8:449-460. 10.1016/j.dnarep.2009.01.005, 19223247.
54. García-Closas MMN, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer RSD, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas, R C-VG, Chanock S, Yeager M, Rothman N. Genetic variation in thenucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:536-542. 10.1158/1055-9965.EPI-05-0749, 16537713.
55. de Angelis PMFB, Kravik KL, Haug T, Tunheim SH, Reichelt W, Beigi M, Clausen OPGE, Stokke T. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. Int J Oncol 2004, 24:1279-1288.
56. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495. 10.1038/sj.leu.2404296, 16791265.
57. Ranganathan S, Tew KD. Analysis of glyoxalase-I from normal and tumor tissue from human colon. Biochim Biophys Acta 1993, 1182:311-316.
58. Batmunkh E, Tatrai P, Szabo E, Lodi C, Holczbauer A, Paska C, Kupcsulik P, Kiss A, Schaff Z, Kovalszky I. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Hum Pathol 2007, 38:1508-1515. 10.1016/j.humpath.2007.02.017, 17640714.